Review



human cdk6 cyclin d3  (Carna Inc)


Bioz Verified Symbol Carna Inc is a verified supplier
Bioz Manufacturer Symbol Carna Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Carna Inc human cdk6 cyclin d3
    Human Cdk6 Cyclin D3, supplied by Carna Inc, used in various techniques. Bioz Stars score: 96/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/CDK6-CycD3/pm24900493__ml200241a_si_001-12-0-6
    Average 96 stars, based on 10 article reviews
    human cdk6 cyclin d3 - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    Phospho-proteomics:

    Article Title: CDK2 inhibitors and methods of using the same
    Article Snippet: .. In the assay, CDK6/Cyclin D3 (Carna Biosciences, 04-107) catalyzed the phosphorylation of a fluorescently tagged peptide 5-FAM-RRRFRPASPLRGPPK-COOH (PerkinElmer, FL Peptide 34) which induced a difference in capillary electrophoresis mobility. .. In the assay, CDK6/Cyclin D3 (Carna Biosciences, 04-107) catalyzed the phosphorylation of a fluorescently tagged peptide 5-FAM-RRRFRPASPLRGPPK-COOH (PerkinElmer, FL Peptide 34) which induced a difference in capillary electrophoresis mobility.

    Electrophoresis:

    Article Title: CDK2 inhibitors and methods of using the same
    Article Snippet: .. In the assay, CDK6/Cyclin D3 (Carna Biosciences, 04-107) catalyzed the phosphorylation of a fluorescently tagged peptide 5-FAM-RRRFRPASPLRGPPK-COOH (PerkinElmer, FL Peptide 34) which induced a difference in capillary electrophoresis mobility. .. In the assay, CDK6/Cyclin D3 (Carna Biosciences, 04-107) catalyzed the phosphorylation of a fluorescently tagged peptide 5-FAM-RRRFRPASPLRGPPK-COOH (PerkinElmer, FL Peptide 34) which induced a difference in capillary electrophoresis mobility.



    Similar Products

    96
    Carna Inc human cdk6 cyclin d3
    Human Cdk6 Cyclin D3, supplied by Carna Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/CDK6-CycD3/pm24900493__ml200241a_si_001-12-0-6
    Average 96 stars, based on 1 article reviews
    human cdk6 cyclin d3 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    90
    Millipore recombinant human full-length cdk6/cyclin d3 protein 14-519
    Recombinant Human Full Length Cdk6/Cyclin D3 Protein 14 519, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/anti+cdk6/pmc09255995__oncotarget___13___28249___s001-7-1-0
    Average 90 stars, based on 1 article reviews
    recombinant human full-length cdk6/cyclin d3 protein 14-519 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore cak-activated recombinant cdk6/cyclin d3
    Cak Activated Recombinant Cdk6/Cyclin D3, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/anti+cdk6/pm39636239-319-19-29
    Average 90 stars, based on 1 article reviews
    cak-activated recombinant cdk6/cyclin d3 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    96
    Carna Inc cdk6 cyclin d3
    Cdk6 Cyclin D3, supplied by Carna Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/CDK6-CycD3/us12065445-2711-3-5
    Average 96 stars, based on 1 article reviews
    cdk6 cyclin d3 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    90
    Millipore active cdk6/cyclin d3 kinase 14-519
    Active Cdk6/Cyclin D3 Kinase 14 519, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/anti+cdk6/pm38316780-339-21-24
    Average 90 stars, based on 1 article reviews
    active cdk6/cyclin d3 kinase 14-519 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore active cdk6/cyclin d3 kinase
    Active Cdk6/Cyclin D3 Kinase, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/anti+cdk6/pmc10844593-333-21-24
    Average 90 stars, based on 1 article reviews
    active cdk6/cyclin d3 kinase - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Promega cdk6/cyclin d3 kinase enzyme system
    Cdk6/Cyclin D3 Kinase Enzyme System, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/kinase+assay/10__3390_slash_molecules25092177-320-25-30
    Average 90 stars, based on 1 article reviews
    cdk6/cyclin d3 kinase enzyme system - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against cdk2, cdk4, cdk6, cyclin d1, cyclin d3, and gapdh
    Downregulation of cell cycle checkpoint proteins involved in the G1 phase transition to the S phase. HCT116 cells were treated with 1 (10 μM, +) for 24 hours or 48 hours, and with vehicle (DMSO, 0.1%). The expressions <t>of</t> <t>CDK2,</t> CDK4, CDK6, cyclin D1, and cyclin D3 were illustrated by Western blot analysis. <t>GAPDH</t> was used as the internal control.
    Primary Antibodies Against Cdk2, Cdk4, Cdk6, Cyclin D1, Cyclin D3, And Gapdh, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/anti+cdk2/pmc06410326-109-17-20
    Average 90 stars, based on 1 article reviews
    primary antibodies against cdk2, cdk4, cdk6, cyclin d1, cyclin d3, and gapdh - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    SignalChem cdk6 cyclin d3 kinases
    A, Plot of replicate Z scores from screening of small molecule compounds capable of enhancing IL-2 secretion from stimulated PD-1-Jurkat cells with compounds annotated as GSK3α/β or CDK4/6 inhibitors labeled. B, Quantification of IL-2 levels by ELISA from PD-1-Jurkat cells treated with PMA/ionomycin or 1 µM CDK4/6 inhibitors and stimulated as indicated for 18h. Results shown as mean ± SD (UT, n=2; other conditions, n=5) (*p<0.05). C, Quantification of IL-2 levels by ELISA from primary human CD4+ T cells treated with 100 nM palbociclib or trilaciclib and stimulated as indicated. Results shown as mean ± SD (UT, n=2; other conditions, n=4) (*p<0.05). D, Immunoblot for CDK4 and <t>CDK6</t> from PD-1-Jurkat cells transiently transfected with the indicated siRNA. E, Quantification of IL-2 levels from PD-1-Jurkat cells after transient transfection with siRNA against Cdk4 or Cdk6 and stimulated as indicated for 18h. Results shown as mean ± SD (n=4) (*p<0.05). Cytokine profiling analysis from human patients using patient-derived organotypic tumor spheroids (PDOTS) cultured in 3-dimensional culturing system at day 1 (F) and day 3 (G). Freshly-obtained patient samples were digested into spheroids and treated with indicated drugs in the 3-D microfluidic system. Cytokine secretion was analyzed by Luminex and expressed as log2-fold change relative to untreated control.
    Cdk6 Cyclin D3 Kinases, supplied by SignalChem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdk6+cyclin+d3/CDK6%2FCyclinD3%2C+Active/pmc05809273-379-33-39
    Average 90 stars, based on 1 article reviews
    cdk6 cyclin d3 kinases - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Downregulation of cell cycle checkpoint proteins involved in the G1 phase transition to the S phase. HCT116 cells were treated with 1 (10 μM, +) for 24 hours or 48 hours, and with vehicle (DMSO, 0.1%). The expressions of CDK2, CDK4, CDK6, cyclin D1, and cyclin D3 were illustrated by Western blot analysis. GAPDH was used as the internal control.

    Journal: Marine Drugs

    Article Title: Saccharoquinoline, a Cytotoxic Alkaloidal Meroterpenoid from Marine-Derived Bacterium Saccharomonospora sp.

    doi: 10.3390/md17020098

    Figure Lengend Snippet: Downregulation of cell cycle checkpoint proteins involved in the G1 phase transition to the S phase. HCT116 cells were treated with 1 (10 μM, +) for 24 hours or 48 hours, and with vehicle (DMSO, 0.1%). The expressions of CDK2, CDK4, CDK6, cyclin D1, and cyclin D3 were illustrated by Western blot analysis. GAPDH was used as the internal control.

    Article Snippet: Then, the membrane was incubated with primary antibodies against CDK2, CDK4, CDK6, cyclin D1, cyclin D3, and GAPDH, purchased from Cell Signaling Technology (Danvers, MA, USA), at 4 °C overnight.

    Techniques: Sublimation, Western Blot, Control

    A, Plot of replicate Z scores from screening of small molecule compounds capable of enhancing IL-2 secretion from stimulated PD-1-Jurkat cells with compounds annotated as GSK3α/β or CDK4/6 inhibitors labeled. B, Quantification of IL-2 levels by ELISA from PD-1-Jurkat cells treated with PMA/ionomycin or 1 µM CDK4/6 inhibitors and stimulated as indicated for 18h. Results shown as mean ± SD (UT, n=2; other conditions, n=5) (*p<0.05). C, Quantification of IL-2 levels by ELISA from primary human CD4+ T cells treated with 100 nM palbociclib or trilaciclib and stimulated as indicated. Results shown as mean ± SD (UT, n=2; other conditions, n=4) (*p<0.05). D, Immunoblot for CDK4 and CDK6 from PD-1-Jurkat cells transiently transfected with the indicated siRNA. E, Quantification of IL-2 levels from PD-1-Jurkat cells after transient transfection with siRNA against Cdk4 or Cdk6 and stimulated as indicated for 18h. Results shown as mean ± SD (n=4) (*p<0.05). Cytokine profiling analysis from human patients using patient-derived organotypic tumor spheroids (PDOTS) cultured in 3-dimensional culturing system at day 1 (F) and day 3 (G). Freshly-obtained patient samples were digested into spheroids and treated with indicated drugs in the 3-D microfluidic system. Cytokine secretion was analyzed by Luminex and expressed as log2-fold change relative to untreated control.

    Journal: Cancer discovery

    Article Title: CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation

    doi: 10.1158/2159-8290.CD-17-0915

    Figure Lengend Snippet: A, Plot of replicate Z scores from screening of small molecule compounds capable of enhancing IL-2 secretion from stimulated PD-1-Jurkat cells with compounds annotated as GSK3α/β or CDK4/6 inhibitors labeled. B, Quantification of IL-2 levels by ELISA from PD-1-Jurkat cells treated with PMA/ionomycin or 1 µM CDK4/6 inhibitors and stimulated as indicated for 18h. Results shown as mean ± SD (UT, n=2; other conditions, n=5) (*p<0.05). C, Quantification of IL-2 levels by ELISA from primary human CD4+ T cells treated with 100 nM palbociclib or trilaciclib and stimulated as indicated. Results shown as mean ± SD (UT, n=2; other conditions, n=4) (*p<0.05). D, Immunoblot for CDK4 and CDK6 from PD-1-Jurkat cells transiently transfected with the indicated siRNA. E, Quantification of IL-2 levels from PD-1-Jurkat cells after transient transfection with siRNA against Cdk4 or Cdk6 and stimulated as indicated for 18h. Results shown as mean ± SD (n=4) (*p<0.05). Cytokine profiling analysis from human patients using patient-derived organotypic tumor spheroids (PDOTS) cultured in 3-dimensional culturing system at day 1 (F) and day 3 (G). Freshly-obtained patient samples were digested into spheroids and treated with indicated drugs in the 3-D microfluidic system. Cytokine secretion was analyzed by Luminex and expressed as log2-fold change relative to untreated control.

    Article Snippet: In vitro Phosphorylation of NFATc3 NMR experiments were performed on a Varian (Agilent DD2 700) spectrometer equipped with a cryogenically cooled probe, and the spectrum was recorded at 287 K. CDK4/cyclin D1 and CDK6/cyclin D3 kinases were purchased from Signalchem.

    Techniques: Labeling, Enzyme-linked Immunosorbent Assay, Western Blot, Transfection, Derivative Assay, Cell Culture, Luminex